Diatrizoate sodium

Diatrizoate Sodium is an iodinated radiopaque X-ray contrast medium. Diatrizoate sodium blocks X-rays, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine and allowing visualization of these areas. This contrast agent is used as a diagnostic aid in angiography, urography and radiography. (In Vitro) :HK-2 cells are exposed to 0-30 mg I/mL Sodium diatrizoate (Diatrizoic acid sodium salt) or vehicle for 2-24 h. MTT and trypan blue exclusion indicate a decrease in mitochondrial and cell viability within 2 and 24 h, respectively. (In Vivo) :Sodium diatrizoate is an iodinated radiocontrast agent. Histological examination of rat lung tissue shows no acute toxicity or inflammation after insufflation of Sodium diatrizoate nanoparticle agglomerates. Sodium diatrizoate nanoparticle agglomerates offers a promising radiocontrast agent for safe and effective lung visualization.

737-31-5

Diatrizoate sodium | Hypaque | MD-50 | MD 50 | MD50 | Triombrin | Urovist Sodium

Pharmacology & Drug Discovery

>98% (HPLC)

Water: 10 mM

CC (Nc1c (I) c (C ([O-]) =O) c (I) c (NC (C) =O) c1I) =O.[Na+]

C11H8I3N2NaO4

635.9

Storage temperature: -20°C. Stability: ≥ 2 years

For research use only.